|Articles|January 18, 2022
Seamless Method Transfer to the Agilent 1290 Infinity II Bio LC System
Author(s)Agilent
Peptide-mapping analysis shows excellent performance and high method compatibility compared to the Agilent 1290 Infinity II LC System.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Distribution Resilience: Meeting Global Demand and Delivering Faster, More Reliable Service
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
Streamlining Procurement and Inventory Management Leads to Increased Productivity
4
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
5
